These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36225865)
1. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease. Hyun YY; Lee KB; Kim H; Kim Y; Chung W; Park HC; Han SH; Oh YK; Park SK; Oh KH Front Nutr; 2022; 9():996674. PubMed ID: 36225865 [TBL] [Abstract][Full Text] [Related]
2. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290 [TBL] [Abstract][Full Text] [Related]
3. The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients. Liao L; Shi S; Ding B; Zhang R; Tu J; Zhao Y; Guo Q; Liao Y Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):369-376. PubMed ID: 37949717 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease. Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662 [TBL] [Abstract][Full Text] [Related]
5. The Association between Serum Creatinine/Cystatin C Ratio and Cardiovascular Morbidity and Mortality: Insights from NHANES. Shi J; Wu Y; Zhu S; Xie Y; Xiang M Rev Cardiovasc Med; 2023 Sep; 24(9):275. PubMed ID: 39076382 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study. Tu X; Lin T; Huang L; Tang T; Xie D; Gao L; Jiang T; Yue J Eur Geriatr Med; 2024 Apr; 15(2):579-588. PubMed ID: 38393457 [TBL] [Abstract][Full Text] [Related]
7. Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease. Lin YL; Chang IC; Liou HH; Wang CH; Lai YH; Kuo CH; Hsu BG Sci Rep; 2021 Aug; 11(1):16863. PubMed ID: 34413438 [TBL] [Abstract][Full Text] [Related]
8. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis. Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777 [TBL] [Abstract][Full Text] [Related]
9. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Cystatin C-Derived Estimated Glomerular Filtration Rate in Patients with Acute Heart Failure. Jang SY; Yang DH; Kim HJ; Park BE; Park YJ; Kim HN; Kim NK; Bae MH; Lee JH; Park HS; Cho Y; Chae SC Cardiorenal Med; 2020; 10(4):232-242. PubMed ID: 32316021 [TBL] [Abstract][Full Text] [Related]
11. Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Vupputuri S; Fox CS; Coresh J; Woodward M; Muntner P Am J Kidney Dis; 2009 Jun; 53(6):993-1001. PubMed ID: 19394726 [TBL] [Abstract][Full Text] [Related]
12. Decreased serum creatinine to cystatin C ratio is associated with low tongue pressure. Komorita Y; Ide H; Yoshinari M; Ohta Y; Nakamichi I; Fujisawa R; Fujii W; Fukuhara M Geriatr Gerontol Int; 2024 Jan; 24(1):102-108. PubMed ID: 38110724 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults. Shi S; Jiang Y; Chen W; Chen K; Liao Y; Huang K Front Nutr; 2022; 9():897774. PubMed ID: 36017221 [TBL] [Abstract][Full Text] [Related]
14. Cystatin C kidney functional reserve: a simple method to predict outcome in chronic kidney disease. Christiadi D; Simpson C; O'brien K; Taylor K; Luxton G; Rossleigh M; Erlich J; Endre ZH Nephrol Dial Transplant; 2022 May; 37(6):1118-1124. PubMed ID: 34043011 [TBL] [Abstract][Full Text] [Related]
15. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours. Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q Front Nutr; 2022; 9():963265. PubMed ID: 36118766 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer. Tsukagoshi M; Watanabe A; Araki K; Ishii N; Hagiwara K; Hoshino K; Muranushi R; Harimoto N; Takizawa M; Shirabe K Ann Gastroenterol Surg; 2023 Sep; 7(5):784-792. PubMed ID: 37663967 [TBL] [Abstract][Full Text] [Related]
17. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619 [TBL] [Abstract][Full Text] [Related]
18. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer. Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814 [TBL] [Abstract][Full Text] [Related]
19. Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients. Shiomi K; Saito C; Nagai K; Kosaki K; Kawamura T; Kaneko S; Kai H; Morito N; Usui J; Yanagi H; Yamagata K Clin Exp Nephrol; 2021 Oct; 25(10):1079-1086. PubMed ID: 34342777 [TBL] [Abstract][Full Text] [Related]
20. Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years. Zhang L; Jin J; Tu YY; Zhao Z; Tao J; Zhang XY Heliyon; 2023 Mar; 9(3):e14214. PubMed ID: 36994407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]